Associate Director, Clinical Operations
Axsome Therapeutics Inc- Full Time
- Senior (5 to 8 years)
Apogee Therapeutics, Inc. (Ticker: APGE), a Nasdaq listed biotechnology company founded in 2022, is seeking an Associate Director, Device Development to lead the development of biologic/device combination products. This role focuses on prefilled syringes with needle safety devices and autoinjectors, supporting clinical supply, commercial manufacturing, and regulatory submissions. The company is committed to building an exceptional culture based on its C.O.R.E. values: Caring, Original, Resilient, and Egoless.
Apogee Therapeutics, Inc. is a biotechnology company focused on developing differentiated biologics for atopic dermatitis, chronic obstructive pulmonary disease, and other inflammatory and immunology indications. The company’s antibody programs aim to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering. They are committed to reshaping the standard of care for inflammatory and immune diseases.
Develops therapies for autoimmune diseases
Abata Therapeutics develops therapies for autoimmune diseases, focusing on type 1 diabetes. Their main product, ABA 201, is a Treg cell therapy aimed at patients with some remaining beta cell function. This therapy works by utilizing regulatory T cells to improve patient outcomes. Unlike many competitors, Abata targets a specific niche within the autoimmune disease market and collaborates with partners like ElevateBio for process development and manufacturing. The company's goal is to transform treatment options for autoimmune diseases through advanced research and development.